A review of current progress in triple-negative breast cancer therapy

Triple-negative breast cancer (TNBC) is a particularly aggressive subtype known for its extremely high drug resistance, progression, poor prognosis, and lack of clear therapeutic targets. Researchers are aiming to advance TNBC treatment worldwide. In the past 2–3 years, more positive results have em...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Meiying, Pan, Huawen, Chen, Yuxia, Xu, Yu Hang, Yang, Weixiong, Wu, Zhaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718625/
https://www.ncbi.nlm.nih.gov/pubmed/33336070
http://dx.doi.org/10.1515/med-2020-0138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718625/
https://www.ncbi.nlm.nih.gov/pubmed/33336070
http://dx.doi.org/10.1515/med-2020-0138

Ejemplares similares